not on schedule, page-21

i read the newsletter i received and it made for interesting reading. PRR are right up there with development of a vaccine that could potentially increase the lifespan of cervical cancer patients. It is truly a wonderful thing but it is also a costly one in that there is little govt funding.

PRR has a good product and have cash in the bank. The management is professional and not just in it to line there pockets.

People that down ramp any stock do it purely for the fact that they want to get in but cannot afford to. They want to have a million stocks but can only afford 1000. Just take youir 1000 and be happy with that. Ive followed this stock for 2 years and it still development time ahead of it but it will be successful, not overnight like greedy peaople would want but in a few years when the patient holders will hopefully prevail and cancer sufferers will get another chance in life.